Overview
Mariarita Calaminici practices practicing medicine in London, United Kingdom.
Their clinical expertise encompasses Splenomegaly, Lymphofollicular Hyperplasia, and Follicular Lymphoma.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mariarita Calaminici
Is Mariarita Calaminici a top-rated expert for Splenomegaly?
MediFind is an objective health platform that identifies experts based on real-world data. Mariarita Calaminici is classified as an Experienced expert for Splenomegaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mariarita Calaminici participate in research or clinical trials?
Yes. Mariarita Calaminici has published 9 articles and abstracts on conditions like Splenomegaly. You can view a list of Mariarita Calaminici's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Follicular LymphomaCalaminici isExperienced. Learn about Follicular Lymphoma.
- Lymphofollicular HyperplasiaCalaminici isExperienced. Learn about Lymphofollicular Hyperplasia.
- SplenomegalyCalaminici isExperienced. Learn about Splenomegaly.